DV Biomed Balance Sheet Health

Financial Health criteria checks 6/6

DV Biomed has a total shareholder equity of NT$500.6M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$617.7M and NT$117.1M respectively. DV Biomed's EBIT is NT$129.6M making its interest coverage ratio 63.9. It has cash and short-term investments of NT$274.6M.

Key information

0%

Debt to equity ratio

NT$0

Debt

Interest coverage ratio63.9x
CashNT$274.59m
EquityNT$500.56m
Total liabilitiesNT$117.11m
Total assetsNT$617.67m

Recent financial health updates

No updates

Recent updates

How Does DV Biomed Co., Ltd. (GTSM:6539) Stand Up To These Simple Dividend Safety Checks?

Mar 22
How Does DV Biomed Co., Ltd. (GTSM:6539) Stand Up To These Simple Dividend Safety Checks?

DV Biomed Co., Ltd.'s (GTSM:6539) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Jan 27
DV Biomed Co., Ltd.'s (GTSM:6539) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

DV Biomed's (GTSM:6539) Earnings Are Growing But Is There More To The Story?

Jan 07
DV Biomed's (GTSM:6539) Earnings Are Growing But Is There More To The Story?

Should DV Biomed (GTSM:6539) Be Disappointed With Their 37% Profit?

Dec 10
Should DV Biomed (GTSM:6539) Be Disappointed With Their 37% Profit?

Are You An Income Investor? Don't Miss Out On DV Biomed Co., Ltd. (GTSM:6539)

Nov 19
Are You An Income Investor? Don't Miss Out On DV Biomed Co., Ltd. (GTSM:6539)

Financial Position Analysis

Short Term Liabilities: 6539's short term assets (NT$451.7M) exceed its short term liabilities (NT$86.8M).

Long Term Liabilities: 6539's short term assets (NT$451.7M) exceed its long term liabilities (NT$30.3M).


Debt to Equity History and Analysis

Debt Level: 6539 is debt free.

Reducing Debt: 6539 had no debt 5 years ago.

Debt Coverage: 6539 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 6539 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 22:34
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

DV Biomed Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution